Atlas Trials

CAMEO: Canadian Methotrexate and Etanercept Outcome Study

Clinical trial NCT00654368 · COMPLETED

Trial details

NCT number
NCT00654368
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2008-06-01
Primary completion
2012-12-01
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.